Event details:

Title: Blood Disorders: Malignant and Non-Malignant


Topic 1: Non-Hodgkin Lymphoma
Speaker: Presented by Dr Denise Lee, Clinical Haematologist
Summary: Non-hodgkin lymphoma is the 6th most common lymphoma in Australia. Over 7000 Australians are diagnosed with lymphoma each year. Dr Denise Lee will provide an update on Non-hodgkin lymphoma and will discuss when patients should be refered on for specialist care. 

Topic 2: Von Willebrand Disease
Speaker: Presented by Dr Alison Slocombe, Clinical Haematologist
Summary: Von Willebrand disease is the most common inherited bleeding disorder worldwide. Dr Alison Slocombe will explore the diagnosis and management of this disease.

Topic 3: Vaccination, Prophylaxis and IVIg in Haematology Patients
Speaker: Presented by Dr Jay Hocking, Clinical Haematologist
Summary: Dr Jay Hocking will discuss the importance of disease prevention in haematology patients, specifically focussing on vaccination, prophylaxis and IVIg. 

Date: Tuesday 15 November, 2022
Time: 7.00pm – 8.30pm
Where: Webinar via Zoom. Dial in from your PC/laptop/mobile phone/tablet
Program: Presentations with Q&A 

Learning Outcomes

  • Identify when to refer patients with lymphadenopathy
  • Outline the role of vaccination, prophylaxis and IVIg in haematology patients
  • Discuss how to assess patients with a suspected bleeding disorder
  • Identify when to refer patients with a suspected bleeding disorder for further investigation


  • 3 CPD Activity points

Event Registration

To register, please provide the following details and a confirmation ticket will be sent to your email. 

  • First name and surname
  • Email address
  • RACGP number or ACRRM number
  • Practice name
  • Practice suburb and postcode
  • Download the flyer for complete information

Please direct your enquiries to [email protected]

Download the event flyer for complete information.


We use cookies to provide you with a customised experience which may include marketing purposes. More details can be found at our Privacy Policy.